Načítá se...
Phase II study of docetaxel in patients with metastatic pancreatic cancer: a Japanese cooperative study
Docetaxel has been reported to show promising anti-tumour activity in pancreatic ductal cancer (PC). This study was conducted to evaluate the activity and toxicity of moderate-dose (60 mg m(−2)) docetaxel in Japanese chemo-naive patients with measurable metastatic PC. The patients had a performance...
Uloženo v:
| Hlavní autoři: | , , , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Nature Publishing Group
1999
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2362341/ https://ncbi.nlm.nih.gov/pubmed/10408850 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6690375 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|